Targeting childhood, adolescent and young adult non-Hodgkin lymphoma: therapeutic horizons.

about

Mortality and survival patterns of childhood lymphomas: geographic and age-specific patterns in Southern-Eastern European and SEER/US registration data.Unique Raman Spectroscopic Fingerprints of B-Cell Non-Hodgkin Lymphoma: Implications for Diagnosis, Prognosis and New Therapies

P2860

Q31131542-53FCBAA9-7137-44B2-907D-904871970BB9 Q57148416-9ABE167E-DC5A-4A8B-94C1-37A3C06C4CD8

P2860

Targeting childhood, adolescent and young adult non-Hodgkin lymphoma: therapeutic horizons.

Item

http://www.wikidata.org/entity/Q38790957

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Targeting childhood, adolescen ...... ymphoma: therapeutic horizons.

@en

type

Item

label

Targeting childhood, adolescen ...... ymphoma: therapeutic horizons.

@en

prefLabel

Targeting childhood, adolescen ...... ymphoma: therapeutic horizons.

@en

P1476

Targeting childhood, adolescen ...... ymphoma: therapeutic horizons.

@en

P2093

Michelle L Hermiston

http://www.w3.org/2001/XMLSchema#string

Paul J Galardy

http://www.w3.org/2001/XMLSchema#string

Tibor Bedekovics

http://www.w3.org/2001/XMLSchema#string

P2860

Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex

mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery

Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia

The genetic basis of early T-cell precursor acute lymphoblastic leukaemia.

A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma

The de-ubiquitinase UCH-L1 is an oncogene that drives the development of lymphoma in vivo by deregulating PHLPP1 and Akt signaling

Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma

Direct inhibition of the NOTCH transcription factor complex

mTOR signaling in growth control and disease

Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)

P304

625-636

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BJH.14016

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

173

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27019108

http://www.w3.org/2001/XMLSchema#string

P921

teenager

Targeting childhood, adolescent and young adult non-Hodgkin lymphoma: therapeutic horizons.

about

P2860

P2860

Targeting childhood, adolescent and young adult non-Hodgkin lymphoma: therapeutic horizons.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921